Russian Sputnik V vaccine has near 92% efficacy
The Sputnik V vaccine, developed in Russia, has been shown to prevent the disease in 91.6 percent of those infected, based on clinical trials. According to interim results published in the Lancet, the vaccine also protects against severe disease transmission.